Breakout 2: Discussion Panel: Business of Neuromodulation in 2023: New Indications, Reimbursement Challenges, & Changing Care Patterns

Speaker(s):

• Dr. Eric J. Grigsby, MD, MBA, Founder & CEO, Neurovations: A Patient Care and Innovation Company
• JoJo Platt, US Partnerships Lead, Corundum Neuroscience, CNS Ventures
• Dan Brounstein, Chief Strategy Officer, Saluda
• Rosana Esteller, PhD, R&D Associate Director & Fellow - Neuromodulation at Boston Scientific, Boston Scientific
• Amy Kruse, PhD, Chief Investment Officer, Satori Neuro
• Suraj Mudichintala, Senior Associate, Action Potential Venture Capital